Apart from driving a highly invasive and metastatic tumoral phenotype, a re-evaluation of earlier reports of GH, EMT, invasion, and therapy-resistance in cancer, collectively does implicate GH in catalyzing EMT-driven evasion of therapy. The gene discussed is GH1; the disease is cancer.